Health - Google News: In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test - FierceBiotech

Health - Google News Google News

In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test - FierceBiotech May 30th 2012, 12:51 In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test FierceBiotech Alnylam's most advanced RNAi drug program has flunked a Phase IIb test for efficacy in treating respiratory syncytial virus (RSV). Just four months after axing a third of its staff, the Cambridge, MA-based biotech ($ALNY) says that ALN-RSV01--one of ... Alnylam lung drug fails mid-stage trialMSN Money Alnylam Announces Top-Line Results of Phase IIb Clinical Trial of ALN-RSV01 ...EON: Enhanced Online News (press release) Alnylam Pharmaceuticals Reveal Positive Results Of Phase IIb Trial Of ALN-RSV01NASDAQ StreetInsider.com (subscription) all 21 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: